Strong First Quarter for IMS Health

Pharmaceutical information giant IMS Health has announced a strong start to the year reporting first-quarter 2006 revenues of US$446.2 million, up 9% on the previous year.

First-quarter 2006 diluted earnings per share on an SEC-reported basis was US$0.56, compared with USD$0.13 in the prior year. Excluding the expense of stock options, on an adjusted basis, earnings per share were US$0.34, a 17% increase on Q1 last year. Including the expensing of stock options, adjusted Q1 eps was US$0.31, up 7%. Net income on an SEC-reported basis was US$118.1 million, up from US$30.3m. Adjusted to exclude stock option expenses, first-quarter net income rose 6% to US$72.1m.

According to IMS Chairman David R. Carlucci, 'IMS had a great start to the year. We continued to build on our momentum and turned in an outstanding operational performance in the first quarter, with impressive gains in each of our regions and exceptional growth in the U.S., our largest market. Our execution across business lines is excellent, reflecting our strong client focus and sustained execution by our teams worldwide. We remain confident that we will achieve our guidance for 2006.'

The company can be found online at www.imshealth.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• IMS Health Inc
• All news